MedPath

Quality of Life After Cytoreductive Surgery and Intraperitoneal Chemotherapy

Not yet recruiting
Conditions
Colorectal Cancer Metastatic
Registration Number
NCT03503071
Lead Sponsor
Kyungpook National University Hospital
Brief Summary

Cytoreductive surgery with intraperitoneal chemotherapy is one of the most important treatments for patients with colorectal cancer and peritoneal metastasis. For the best survival rates, complete removal of all metastatic lesions is the most important part of treatment, and various surgical procedures are required for the complete cytoreduction. Therefore, the postoperative morbidity rates are higher than those of localized colon cancer surgeries and patients can experience a prolonged recovery period and deterioration of physical activities over a long period. The aim of this study is to investigate the change of quality of life after cytoreductive surgery and intraperitoneal chemotherapy for colorectal cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Colorectal cancer peritoneal metastasis
  • Pseudomyxoma peritonei
  • ECOG (Eastern Cooperative Oncology Group) performance status 0-3
  • Normal bone marrow, kidney, and liver function
  • Patient must sign and date the informed consent
Exclusion Criteria
  • Palliative surgery
  • Palliative intraperitoneal chemotherapy
  • Psychotic disorder
  • Drug abuser

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Brief pain inventory (BPI)Changes from baseline pain scores at postoperative 12 months

Pain recovery after cytoreductive surgery and intraperitoneal chemotherapy

Secondary Outcome Measures
NameTimeMethod
European Organisation for Research and Treatment of Cancer (EORTC) Quality of life questionnaire (QLQ)-C30preoperative, postoperative 3 months, postoperative 6 months, postoperative 12 months, postoperative 24 months

Qualify of life questionnaire for cancer patients

EORTC QLQ for colorectal cancerpreoperative, postoperative 3 months, postoperative 6 months, postoperative 12 months, postoperative 24 months

Quality of life questionnaire for patients with colorectal cancer

Short-form(SF)-36preoperative, postoperative 3 months, postoperative 6 months, postoperative 12 months, postoperative 24 months

Global measure of health-related quality of life

Postoperative morbidity90 days after surgery

Incidence and degree of surgical and medical complications after surgery

Postoperative mortality90 days after surgery

Incidence of postoperative mortality

Brief pain inventory (BPI)preoperative, postoperative 3 months, postoperative 6 months, postoperative 24 months

Pain recovery after cytoreductive surgery and intraperitoneal chemotherapy

Postoperative recovery150 days after surgery

Duration of hospital stay after surgery

Trial Locations

Locations (1)

Kyungpook National University Chilgok Hospital

🇰🇷

Daegu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath